Akzo Nobel N.V. (AMS:AKZA)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
52.30
-0.52 (-0.98%)
Apr 24, 2026, 5:38 PM CET
← View all transcripts

Earnings Call: Q3 2024

Oct 23, 2024

Operator

Thank you, and good morning, everybody. I would like to welcome you all to the AkzoNobel Q3 Results 2024 conference call. My name is Brika, and I will be coordinating your call today. During the presentation, you can register to ask a question by pressing star followed by one on your telephone keypad. If you change your mind, please press star followed by two, and for operator assistance at any point, it's star zero. Thank you. I would now like to hand you over to our host, Kenny Chae, Head of Investor Relations, to begin. So please go ahead, Kenny.

Kenny Chae
Head of Investor Relations, AkzoNobel

Thank you, Brika. Good morning, and welcome to AkzoNobel's investor update for the third quarter of 2024 . I'm Kenny Chae, Head of Investor Relations. Today, our CEO, Greg Poux-Guillaume, and CFO, Maarten de Vries, will take you through our results. We'll refer to the presentation, which you can follow by webcast or download from our website at akzonobel.com. A replay of the webcast will also be made available following the event. There will be a Q&A session after the presentation. For additional information, please contact our investor relations team. Before we start, a reminder of our forward-looking statements disclaimer on slide two. Please note this also applies to the conference call and answers to your questions. I will now hand over to Greg, who will start on slide three of the presentation.

Greg Poux-Guillaume
CEO, AkzoNobel

Thanks, Kenny. Good morning to everyone on the call. Apologies for my voice. I need to trade in my company bicycle for a company car, probably in this weather, but hopefully, hopefully you can hear me fine. Q3 is our fourth consecutive quarter of volume growth. Volumes increased by 1%, even as market conditions remain mixed. Price mix was flat, as pricing benefits were offset by a negative regional mix of 1%. Our gross margin continued to improve.

Adjusted gross margin expanded by 60 basis points in Q3 and 180 basis points year to date. Adjusted EBITDA growth in the quarter was impacted by higher-than-expected adverse currencies. While OpEx was higher year -on- year, it was down sequentially from Q2 levels as our cost measures begin to yield benefits.

This will only accelerate in the next quarters, given the additional SG&A measures that we announced. Q3 adjusted EBITDA before hyperinflation accounting was EUR 400 million, in line with guidance, resulting in an EBITDA margin of 15%. Our net debt to EBITDA ratio, while down year- on- year, increased to three times from the prior quarter, mainly due to temporary elevated working capital. Moving to slide four. Let's look at the initiatives that support our ambitions. In May, we announced the closure of three Deco European EMEA sites as part of our industrial efficiency program. These closures should be completed by year-end, with volume transfers nearly over already. The next wave of closures is in preparation and will be announced in early 2025.

We reaffirm the benefit targets outlined in our half-year results, EUR 25 million this year, EUR 17 million next year, and north of EUR 250 million overall. Incremental to our industrial efficiency program, we announced in September an SG&A program with cuts that will optimize our functional organization. We're too heavy, and we have to get leaner, particularly with rising labor costs. We're simplifying and rationalizing our organization. This will lead to a reduction of 2,000 positions globally, functional positions, a lot of them in Europe, and will deliver annualized savings of EUR 120-EUR 150 million . Actions are already underway and should be largely implemented by the end of Q1 2025, although the benefits will spread out over time as people exit our payroll, which takes a little bit of time in Europe.

At the start of October, we initiated a strategic review of our portfolio. Our intent is to focus our capital allocation on positions of differentiating scale, particularly in our key coatings markets. The initial focus of the review is on Decorative paints in South Asia, where AkzoNobel is present in a number of countries. In India, particularly, we have a premium, highly profitable position, but with limited market share in a market that is ripe for consolidation. We're well-placed to participate in this consolidation, and this can take different forms, which we are evaluating. We do not have a set timeline for this review, and we're focused on getting to the right outcome rather than a speedy outcome. We'll update you as we progress. Together, these initiatives position us to be a winner in our core markets.

They'll sharpen our competitive edge and accelerate our transformation towards sustained profitable growth. Let's now turn to slide five. Organic volumes in Q3 were up 1%, with 2% growth in coatings and flat performance in Deco. Looking at our businesses one by one, starting with Decorative paints. In Deco, Europe, Middle East, and Africa, Q3 volumes remained flat, with a robust performance in the UK and in the Benelux, offset by weaker demand in Central and Southeast Europe. We expect mixed trends to continue, likely resulting in flat to slightly negative volumes in Q4. Turning to our emerging Deco markets, Latin America delivered mid-single-digit growth on solid performance in Brazil, while Colombia remained soft. In Southeast Asia, strong growth continued in Q3 with double-digit growth, primarily driven by Indonesia and India, while Vietnam stabilized.

For Q4, we expect mid-single-digit growth for these two regions combined. In China, demand continued to be weak due to a challenging real estate market and low consumer confidence. Although recent economic measures signal a potential rebound, we view this more as a 2025 opportunity. I'd highlight that, as you know, China is about 14% of our sales overall. Half of it is Deco, half of it is coatings. The Deco business is down significantly in terms of volume this year, but the coating businesses are doing really well and continue to grow. So, I urge you to have a balanced view of China. If you take our Q3 numbers in coatings in China, so not Deco, but coatings, our volumes are actually up mid-single digits.

Let's now move to our coating businesses. In powder, we achieved another strong quarter with mid-single-digit growth, despite flat markets and softness in the automotive segment. Marine and protective also performed well, driven by technical new builds in marine, while protective faced mixed market conditions. We expect mid-single-digit growth for these two businesses to continue in Q4. Automotive and specialty volumes were slightly lower, with a clear slowdown in the automotive market and softness in vehicle refinish. The vehicle refinish in Q3 actually showed growth, but we see that market as a little bit softer going forward. Aerospace generated solid growth, particularly in our aircraft maintenance business, but the OEMs, Boeing and Airbus, primarily, are slowing down production, either due to strikes in the case of Boeing or supply chain issues in the case of Airbus.

For Q4, we expect volumes to be flat to down. In industrial coatings, demand weakened in packaging and coil, while wood adhesives delivered solid performance. We anticipate further softening into Q4 on declining industrial demand, which could result in a mid-single-digit contraction. In summary, we're delivering growth despite flat to declining markets. Given further deterioration in some markets, we expect flat volumes in Q4. Maybe I'll take that as an opportunity to comment on the Q3 volumes if you exclude China Decorative. Our Q3 volumes were actually closer to 3%- 4% up in Q3, if you exclude China Decorative. If you apply the same reasoning to Q4, we'll still be down double-digit versus last year in Q4 in China Decorative.

So actually, the underlying volume trends at AkzoNobel, excluding China Decorative, are more in the sort of low to mid-single digits in Q3 and low single digits in Q4. So it's more robust than it looks, but China Decorative hasn't bottomed out in the sense that it's not that the market is dropping. It's more that we're still chasing comps that are a little bit higher last year. But as the market settles and as some of these stimulus measures start taking hold, we think we'll see a little bit of an upswing in Q4. Maarten, over to you.

Maarten de Vries
CFO, AkzoNobel

Yeah. Thanks, Greg, and good morning.

Greg Poux-Guillaume
CEO, AkzoNobel

I'm sorry. We'll see an upswing next year, not in Q4. Q4 will still be down in China Decorative-

Maarten de Vries
CFO, AkzoNobel

Yeah.

Greg Poux-Guillaume
CEO, AkzoNobel

given the baseline of last year. Maarten?

Maarten de Vries
CFO, AkzoNobel

Yeah, it's good that you clarified that. Thanks, Greg, and good morning, everybody on the call. Our Q3 results were in line with prior quarter and our guidance when adjusted for FX headwinds that worsened in the quarter. Organic sales grew with 1% in the third quarter, though reported revenue was down 3%, primarily due to FX. The volumes were up 1%, with growth in coatings driving results, while Deco volumes remained flat. Price mix was flat, with positive pricing offset by negative regional mix of 1%. Adjusted EBITDA, including impact of hyperinflation accounting, was EUR 394 million. This reduction to prior year reflects higher year-over-year operating costs, though these costs are now trending down sequentially. Our cost mitigation measures are progressing well and expect to make further headway with our SG&A actions, as Greg outlined earlier.

Turning now to slide seven. Our year-to-date return on investment of 13.4% shows a solid expansion versus prior year. This marks a solid step towards our midterm range of 16%-19% ROI. Working capital as a percentage of revenue stood at 17.7%. This was influenced by elevated inventory levels, which were primarily a result of mixed demand in some end markets. We are stepping up our efforts to reduce inventory and working capital. We expect working capital to land at the end of the year at around 15%, a bit higher than we initially targeted. We still aimed to get back towards the 13% of sales by the end of next year. Leverage was three times at the end of the third quarter.

Despite the temporarily high working capital, we delivered solid free cash flow of EUR 270 million in the quarter. With that, I'll hand over back to Greg to discuss our outlook on the next slide.

Greg Poux-Guillaume
CEO, AkzoNobel

Thanks, Maarten. We delivered in Q3, our fourth consecutive quarter, combining volume growth and gross margin expansion, while starting to reduce our operating expenses. Our ability to defend pricing while capturing growth shows that we can adapt and perform in volatile markets. Adjusted for higher Forex, our adjusted EBITDA in Q3 was identical to Q2, in line with our guidance. Our operating costs are now trending down sequentially. We launched further cost and portfolio initiatives during the quarter to support our midterm ambitions. We're excited by the progress we're making and remain confident in our ability to deliver sustainable, profitable growth. For the full year of 2024, we expect to achieve adjusted EBITDA growth to around EUR 1.5 billion, and to finish the year with a net debt to EBITDA ratio of 2.7x .

The 2.7 x is the consequence of two things versus our previous guidance of 2.3x. We said that we'd be at around 14% of sales working capital and 14% of sales by the end of the year will be 100 basis points higher, so it'll be 15% of sales. The rest of it is not working capital or restructuring cash out. It's that the net debt to EBITDA is based on reported EBITDA and the SG&A measures linked to additional restructuring and therefore identified items, and therefore that lowers the reported EBITDA. Now, Maarten can do the math for you if you want as the follow-up, but these are the drivers of the 2.7x.

I'll now hand over to Kenny, who will close with information about upcoming events, and then we'll do the Q&A. Kenny?

Kenny Chae
Head of Investor Relations, AkzoNobel

Thank you, Greg. Before we start the Q&A, I would like to draw your attention to the upcoming events shown on slide nine. The ex-dividend date of our 2024 interim dividend is on October 28, and the record date is October 29, followed by payment on November 7, and we plan to publish our fourth quarter results on January 29, 2025 . This concludes the formal presentation, and we would be happy to address your questions. Please state your name and company when asking a question, and limit the number of questions to two per person so others can participate. Operator, please start the Q&A session.

Operator

Thank you. As a reminder, if you would like to ask a question, please press star followed by one on your telephone keypad. If you change your mind, please press star, then two. We have the first question on the phone lines from Thomas Wrigglesworth with Morgan Stanley.

Thomas Wrigglesworth
Head of Chemicals Europe, Morgan Stanley

Good morning, everybody. Thanks very much for the presentation. My two questions. The first one, could you unpack a little bit further the ambition behind the restructuring in Southeast Asia? Could you give us a little bit of a sense of, you know, what the best outcome looks like and what you would do with proceeds or, having restructured Southeast Asia, where you might look to restructure next? First question. The second question, just to clarify on this net debt to what the actual net debt that you are anticipating at year-end is, should we be thinking something in the region of the kind of EUR 3.7-EUR 3.8 billion level? Is that the right way to think about it? Thank you.

Greg Poux-Guillaume
CEO, AkzoNobel

Thanks, Thomas. I'll take the first question, Maarten will take the second. In South Asia, it's really a portfolio management, portfolio evaluation. We're looking at these positions where we have actually strong businesses, but strong businesses without leading market positions. And in markets where there's a potential for consolidation and there's a path to scale, then we're very happy to be leading the way. But in markets where there are more natural consolidators, we're very happy to be either a minority partner or to exit altogether. And South Asia, the main countries for us are India, Pakistan, Sri Lanka. I mean, in that region, the main topic is India. Our business in India is publicly traded.

I think market cap is around EUR 2 billion, if you, if you convert currently. And, if you look at the profitability where we disclose, well, despite the fact that we've got 5% market share, give or take, we are, one of the most profitable, if not the most profitable player in the space, because we have a very strong premium position. Dulux is actually celebrating 70 years in India this year, so it tells you that we are the, we're the standard. And as the market consolidates, you've been observing India, I'm sure, where you see that there's people pushing in, like, the Grasim and guys from the cement sector. There's Asian Paints solidifying its position.

There's other companies also trying to figure out what their differentiating assets are over time. It's a good time to have conversations with the various market players to see how we can contribute to a winning hand, a winning play over time. But once again, it can range all the way from a partnership where we'd be the junior partner, because we do that with somebody that has a stronger distribution than us, for example, all the way to a potential disposal. And to your question as to whether there are other countries in Asia that where we can ask ourselves the same question, potentially, but in some of those countries, we also see a way to get to a leading position, not just a profitable position.

So, we'll talk more about that over time. Right now, the focus is on South Asia. And then in terms of proceeds, I mean, it's way too early to count our chickens here. We'll make sure we make the right portfolio moves, and we come to the best outcome, and then we'll talk about proceeds. But overall, Akzo is focused on a balanced capital allocation that includes share buybacks, particularly if our share price is where it's at today. And capital deployment into our core businesses and our capital deployment going forward is more likely to be in Coatings than in Deco. Maarten, take the second question?

Maarten de Vries
CFO, AkzoNobel

Yeah, on your question on the net debt, you mentioned a range of EUR 3.6-EUR 3.7 billion. Actually, it's in that range, but then in the high end of the range, so it is more closer to the EUR 3.7 billion. That is our assumption for the net debt by the end of the year.

Greg Poux-Guillaume
CEO, AkzoNobel

Did we answer your questions, Thomas?

Thomas Wrigglesworth
Head of Chemicals Europe, Morgan Stanley

Okay. Thank you both. Yeah.

Greg Poux-Guillaume
CEO, AkzoNobel

Thanks a lot.

Thomas Wrigglesworth
Head of Chemicals Europe, Morgan Stanley

Very clear. Thank you. Thank you both.

Operator

Thank you. Your next question comes from Christian Faitz with Kepler Cheuvreux. You may proceed.

Christian Faitz
Equity Research Analyst, Kepler Cheuvreux

Yes, thanks, good morning. Two questions, please. First of all, why do we expect the car refinish market going softer? Is it changed insurance policies, less miles driven, people not getting their cars repaired due to economic hardship, or all of the above? And then the second question is, one of your key competitors looks at selling its Brazilian Deco activities. Some market participants might not even have noticed that this peer had a Deco business. In any case, can I just confirm that simply looking at combined market share in Brazil, this business is not an option for you? And are any of the other activities that that competitor is putting on the block in Coatings of interest to you? Thanks.

Greg Poux-Guillaume
CEO, AkzoNobel

All right. I'll take those questions. Vehicle refinish has slowed down a little bit. I think we commented on that, I think PPG commented on something similar. In the U.S., it's in part because there's been large mergers in the distribution space, and there's some adjustments as the dust settles. But there isn't anything structurally problematic. We're just observing that the volumes are a little bit lower than they've been. And you know, might be a little bit of a wait-and-see attitude in terms of people getting things repaired. But I wouldn't want to make too much out of it than it is.

Just trying to guide that, we've been saying consistently that vehicle refinish was dynamic, and currently, vehicle refinish is slower, both in the U.S. and in Europe. Your second question is, you know, it's a BASF question. It's y ou're talking about the Suvinil business in Brazil, which is our direct competitor in Decorative paints. And I think the question you're asking is, we're number one and number two. The first part of the answer would be that, we're not looking currently to deploy additional capital to Deco in Latin America. We made the Orbis acquisition. We're still digesting it, extracting the synergies.

That's our focus today, not on deploying further capital in Latin America in Deco. Would we, you know, so do I rule out participating? I mean, you know, I'll help the BASF guys by maintaining the suspense so that they can drive up the price. I think it's a really good asset, and I know there'll be very interested parties because Brazil is an important market to be in. It's a good market. And once again, BASF, although they only had one Deco business, it happened to be a strong Deco business in Suvinil. So, I root for them to extract a good price out of it, but once again, we're not looking to deploy additional capital in Latin America in Deco.

Your question as to whether the rest of BASF, I think you're alluding to BASF Coatings, whether that would be of interest. Yeah, it's of interest. I mean, it's... We've made no bones, no secret about the fact that that business or some parts of that business, even all of that business, could be a good fit with AkzoNobel, but it's too early to comment on any of that. I think BASF has a lot of things on its plate right now, between the Catalyst disposal, the Deco Brazil disposal, and I think the agro business, agri business IPO that they're planning. So let's wait until BASF decides what they want to do before we start speculating on what combinations would make sense.

Christian, any follow-up, or was that clear?

Christian Faitz
Equity Research Analyst, Kepler Cheuvreux

Nope, that was very clear. Thanks, Greg.

Greg Poux-Guillaume
CEO, AkzoNobel

Thanks a lot.

Operator

Thank you. Your next question comes from Chetan Udeshi with JP Morgan. Your line is open.

Chetan Udeshi
Executive Director, JPMorgan

Yeah, hi. Thanks for taking my questions. I just wanted to come back to the working capital point because, you know, we've been waiting for this number to come down, not this year, but actually over the last two years, and I'm just curious, you know, working capital is something that, you know, you can proactively manage, and yes, the volumes have been weaker, but it doesn't feel like it's been terribly weaker, so I'm just curious where things are not going right in terms of working capital reduction, because it seems, you know, this has been an ongoing focus for close to two years now. The other question I had was just looking into different buckets across your businesses.

You know, you managed to keep the pricing flat to up, which is, which is a pretty good achievement in an environment like we've been for the last two years. I'm just curious, do you see any changes in Q4 or as we look into 2025 in terms of pricing across any of your businesses?

Greg Poux-Guillaume
CEO, AkzoNobel

Thanks, Chetan. Maarten will take the working capital question, and I'll take the pricing question. Maarten?

Maarten de Vries
CFO, AkzoNobel

Yeah. So on working capital, you're right. If you look at working capital, the key focus for us is the inventory levels. And inventory levels have not been normalized yet as we want them to be because from a days inventory outstanding, we're still north of the 100 days, and you know that normalized levels are more in the 90s. What is not helping is mixed and dynamic markets. So some of the volatility doesn't help us to structurally bring it down. There is a lot of focus to address this, and as we said earlier, we will make a step in Q4.

You will also see working capital coming down from the current 17.7% to around 15% in the fourth quarter, and we plan to make further steps next year. But your point is absolutely fair, that we are not yet there where we want to be in terms of normalizing our inventory levels.

Greg Poux-Guillaume
CEO, AkzoNobel

And then the pricing question, we don't see any changes in the pricing trends. It's competitive markets. We certainly feel that all around, but we've been able to defend pricing quite well. If you take the index contracts, in our case, we see that as you know, the price give backs linked to raw material indices. We see that as a story that is essentially complete. So we see the price give back in the index businesses, particularly our industrial coatings business, which is packaging and coil. We see that we're at the end of that story. I know one of our competitors commented on the fact that this could go another one or two quarters, but we think that's flattening out.

We're all as we look into next year, you know, the markets are not buoyant, but they're not depressed either. We are shifting back to the way companies ran their business in a world that had a little bit of inflation, you know, that 3%-4% inflation, which is what we will have. Price increases very early in the year that will reflect some of these additional costs, including some of the cost increases by the tariffs on TiO2 from China and Europe. And all of that will happen in Q1.

So we're back to our regular program, except that in the case of AkzoNobel, it's a little bit better than what our regular program used to be. It's essentially price discipline in a world of 3%-4% inflation. Chetan, did we answer, or do you have a follow-up?

Chetan Udeshi
Executive Director, JPMorgan

Can I ask a follow-up, slightly different one, which is, Greg, when you came, initially, I think the message we got from you was, you know, Akzo has done too much cutting of cost, and maybe in the hindsight, that has also impacted the growth, potential of the business. And I think now we are seeing the same sort of dynamic again, that you've announced, 2,000 job cuts. I mean, how is this different from the past?

Greg Poux-Guillaume
CEO, AkzoNobel

Yeah, it's a good question.

Chetan Udeshi
Executive Director, JPMorgan

Is this a bit of a course correction in your view, that, you know, frankly, the only way to grow earnings here is through cost cutting?

Greg Poux-Guillaume
CEO, AkzoNobel

No, no, no, it isn't. And, you know, it's a fair question, but I think it ignores something important, which is that our cost cutting is functional. And, Maarten is sitting next to me, and I love Maarten, and I have the utmost respect for the finance function, but there's, there isn't a business alive that's hasn't been able to grow because instead of having three business controllers, it had two in one part of its business. You know, it's. You need to have a certain functional quality, and you need to be able to have the KPIs that are important to running the business, and you need to able to extract the analysis that allows you to do intelligent things on pricing and the likes, but.

Functional organizations are, you know, costs that need to be addressed. And, as much as we're protecting the commercial functions, we are hitting the corporate functions a lot harder, and this is where you're seeing a lot of the 2,000 people that we're talking about. Beyond that, we're simplifying organization fairly significantly, and that's driving the functional cuts. In our coating businesses, we had taken the manufacturing and supply chain out of the businesses, and we were managing that transversely.

It generated a lot of efficiencies in terms of best practices and making sure that our footprint issues were being addressed, but it also created a lot of functional handovers, and as we reintegrate these businesses end to end, that functional overweight can be removed. So we're very careful to target our costs without targeting the muscle that drives the growth.

And once again, these are functional cuts. I'm not underestimating the importance of functions in an organization, but I, you know, having done this before in other environments, I once again, this is not going to be an excuse for us to grow slower. Chetan, hopefully I answered your question.

Chetan Udeshi
Executive Director, JPMorgan

That's very clear. Yeah, that's very clear, Greg. Thank you.

Operator

Thank you. We now have Geoff Haire with UBS. You may proceed.

Geoff Haire
Head of European Chemical Equity Research, UBS

Hi, guys. I was just wondering if I could ask two related questions on China. First of all, as you look at the China Deco business, is this sort of strategy just wait until the market recovers and try and keep costs at a minimum to sort of keep profits up? And also related to that, when you looked at what businesses you wanted to put under strategic review, why was the China Deco business not within that remit? Because, you know, if you look over the last probably five years, China Deco business has been a little bit of a roller coaster for AkzoNobel.

Greg Poux-Guillaume
CEO, AkzoNobel

Yeah. I mean, the roller coaster point is a valid one. It was a really good business until about two years ago, really good business in terms of profitability. I mean, it was accretive to our Deco business until two years ago, and, like, we're in the dropping part of the cyclone. I'm not talking cyclone in terms of storm. I think I'm referring to that roller coaster in Coney Island, you know, so it's, we're. That market has dropped significantly. You know, being precise here, so you don't say Akzo is in the eye of the storm or something like that, you know, which will get me in trouble.

The reason we like that business is that we're actually number two in Deco in China. Now, if you look at it, you can go like, "Well, isn't Sankeshu number two?" But actually, we don't play in projects. We have a limited exposure to projects. You know, projects for large volumes for real estate developers, that market's been hammered. So, but we essentially largely stepped out of it a few years back. But if you take the retail market, we're number two in a really important market. Our debate was what do we have to do so we avoid being a marginal premium player?

Because, if you see what happened in the China market in Deco the last few years, there's been consolidation driven by Nippon and Sankeshu, and essentially that consolidation has been achieved by taking volumes from smaller domestic players. Akzo largely until the volumes dropped recently, Akzo has largely remained flat, but remained flat by performing well in premium and being a marginal player in everything else. We worked to rebalance the portfolio a little bit because as you expand into China's Tier 2 cities, you want to be more than just premium in order to make the distribution equation work. And we're still working on that. So we're working on our expansion into the smaller cities, and we're working on rebalancing our portfolio to be more competitive in the mid-market.

As we do that in a market that's been dropping, so it doesn't look very good from a numbers perspective, but it's also our belief that the China economy is gonna stabilize and then pick up. So, there's no urgency to do anything. The urgency really for us is to consolidate that number two position and to be a strong player for the long term in China. You know, if the final part of the question is, will there be further consolidation in China and Deco? Possibly. We'll see. But right now, it doesn't seem to be the main move that's happening in the market.

It's more a question of finding the bottom, which we think is pretty much where we are today, and then extracting the benefits of all the actions that we've undertaken when volumes start picking up and these actions and these benefits become visible, which are not today. Hopefully, I've answered your question?

Geoff Haire
Head of European Chemical Equity Research, UBS

Yeah, can I just follow up? I think-

Greg Poux-Guillaume
CEO, AkzoNobel

Yeah.

Geoff Haire
Head of European Chemical Equity Research, UBS

In your pre-prepared remarks, you mentioned there would be an upswing next year in China. What gives you the confidence that that will happen?

Greg Poux-Guillaume
CEO, AkzoNobel

I mean, we've been positive before, so I don't wanna be the guy that is calling the bottom in the pickup in China. But when we look at our volumes and we look at how the market's been for the last few months, first of all, collectively, the market's stopped pricing down. The guys who were pricing down, it was Nippon Paint, so let's be clear. I love them dearly, but they were really aggressive in order to make up for the volumes that they'd lost on the project side of the business. They've actually stabilized their pricing since the summer, and if you look at the market overall, the volumes are no longer dropping sequentially.

In some areas, they're picking up a little bit. So there are signs that we found a bottom, and then if you look at the stimulus that's currently happening, I mean, it's paying off a lot more in the industrial businesses than it is in Deco, because Deco is consumer confidence related. And I think the big challenge for the Chinese government is how do you get the real estate market to pick up again without recreating the same problem that you had before? So I think we have to be a little bit more patience-- patient, I'm sorry. But the combination of pricing that's stabilized since the summer and volumes that are picking up in certain areas, that, you know, essentially signals that that we are ripe for the beginning of a pickup.

And how quickly that will happen, I actually have no clue. But we don't expect the market in China to be down next year in Deco. We expect it to be, I'd call it slightly up, but we'll comment on that with the full year results as we give guidance for 2025. All right? Other questions?

Geoff Haire
Head of European Chemical Equity Research, UBS

Okay, thanks.

Greg Poux-Guillaume
CEO, AkzoNobel

Thanks.

Operator

Thank you, Geoff. Your next question comes from Laurent Favre with BNP Paribas. Your line's open.

Laurent Favre
Head of Automotive and Chemicals Research, BNP Paribas

Thank you, and good morning. Greg, you mentioned that we are resuming or we are returning to normal service in terms of pricing. I mean, normal service, I guess, in terms of fixed cost inflation, used to be between EUR 100 million and maybe EUR 150 million. I was wondering if this is the kind of number that you would be expecting for 2025. And on the flip side, given all the different initiatives on the simplification plan, the restructuring that you said would be effective by the end of Q1, I mean, should we be assuming that your cost cutting can offset fixed cost inflation, and then we should see net fixed cost as a positive driver? Thank you.

Maarten de Vries
CFO, AkzoNobel

Yeah, Laurent, let me pick up this question. So yes, I mean, cost inflation will start to normalize from what we've seen specifically this year. So that is one. But to your point, with all the actions we are taking, our industrial program as well as the actions we're taking with the on the SG&A side, we overall, from an OpEx perspective, we expect costs to be below this year. At this stage, we will not be specific yet. We will come back and be more specific when we give guidance for 2025 , but that is what I can confirm or reconfirm at this stage.

Greg Poux-Guillaume
CEO, AkzoNobel

It'd be really disappointing, Laurent.

Laurent Favre
Head of Automotive and Chemicals Research, BNP Paribas

Thanks, Maarten.

Greg Poux-Guillaume
CEO, AkzoNobel

It'd be disappointing if we continue chasing our tail. You know, there's a moment where, as inflation stabilizes, and as we move away from that EUR 200 million a year impact that we had the last two years, and as you layer in all these measures, you know, there's a moment where that has to point the arrow upwards. Otherwise, the model doesn't work, and we do think that moment is next year.

Laurent Favre
Head of Automotive and Chemicals Research, BNP Paribas

Thanks, Greg. And as a follow-up, I think in the prepared remarks, you talked about aerospace being flatter down volume-wise in Q4. Was that just on the OE part, or is that including maintenance and repair?

Greg Poux-Guillaume
CEO, AkzoNobel

No, it's OEM. If you benchmark us with

Laurent Favre
Head of Automotive and Chemicals Research, BNP Paribas

Okay.

Greg Poux-Guillaume
CEO, AkzoNobel

If you benchmark us with PPG, you know, PPG said aerospace is good, but as you know, PPG is very much, defense and business aviation. The lion's share of the market is the OEMs and the MRO. MRO is okay, OEM is slow for the reasons you know at Boeing and Airbus.

Laurent Favre
Head of Automotive and Chemicals Research, BNP Paribas

Thanks, Greg. Thank you.

Greg Poux-Guillaume
CEO, AkzoNobel

Thanks, Laurent. Other questions?

Operator

Thank you. We now have Aron Ceccarelli with Berenberg. Please go ahead.

Aron Ceccarelli
Equity Research Analyst, Berenberg

Hello, gentlemen. Good morning. Thanks for taking my questions. My first one is on the portfolio review of Southeast Asia. I just wanted to clarify that includes also Vietnam and Indonesia. And also, I mean, considering Vietnam, India is a growing market, good business for you, how quickly you think you can pull this out? And do you think you can do it, like, in a package if includes other countries, or you need to go with India first? The second question is around the proceeds from this portfolio review. You mentioned you want to invest more in coatings.

That would be interesting to understand what areas you see the opportunities here, and what the kind of orders of priority would be for the capital deployment of this proceeds if you don't find any kind of proper opportunity. And the final one would be on cost. This EUR 120 million-EUR 150 million cost cutting you recently introduce, maybe can you be a little bit more specific about the cadence of this benefit going to 2025, please? Thank you.

Greg Poux-Guillaume
CEO, AkzoNobel

All right. Thanks, Aaron. I'll take them backwards. The cadence of the SG&A cuts, I said earlier that they'd be completed, the actions would be completed by the end of Q1. It doesn't mean you get the full P&L impact at the end of Q1, because you have to have people drop out of your payroll, which, once again, for a bunch of legal reasons, takes a bit longer in a number of countries. So we're not giving a number yet for next year, because we'll do that as we give guidance for next year.

You know, I think what that tells you is that it's happening reasonably early in terms of actions and that you'll only get part of the impact next year. We'll qualify what that part of the impact is when we start guiding for next year. Your question on capital allocation linked to potential disposals. We can't buy if we don't sell. We're still working down our leverage to our, you know, our settling point around two times net debt to EBITDA. We're not selling specifically so we can buy. We're actually looking at our portfolio to see which positions can be consolidated into leadership positions and which ones can't.

Our focus right now, as I said, is on South Asia, which is, you know, if you list countries, that's, you know, India, Pakistan, Sri Lanka, and the neighboring countries. As to your question, whether Vietnam and Indonesia are included, I, you know, I said earlier that we can ask ourselves similar questions on other Deco markets in Asia, but I also said that some of these Deco markets, we have a path to leadership, and therefore, we as much as in South Asia, we're unlikely to be the consolidator, in these other areas we could be.

That's it. It's a bit too early to comment, but don't underestimate the strength of our business in Vietnam or in Indonesia. Any follow-up, Aaron?

Aron Ceccarelli
Equity Research Analyst, Berenberg

No, maybe just on the order of priorities when it comes to the capital deployments once you sell India. And also, I mean, the question was also how quickly you think you can pull this portfolio review on India?

Greg Poux-Guillaume
CEO, AkzoNobel

How quickly we can pull the portfolio thing on India? India is a complicated market. It's a publicly traded entity. You know, so there's a lot of, o ne, we wanted to make sure that we find the we choose the right outcome for these businesses and, you know, something that maximizes value for our people, value for Akzo, and creates the strongest partnership out there in order to take the fight to the market, you know, going forward. And, two, you know, once again, these legal intricacies linked to executing something like that in India will take a little bit of time. So we're not on time pressure. We're not on a clock.

The business is doing really well. If anything, it'll only get more attractive as we progress. So we'll take the time that we need on this. And then the capital allocation question, I could pass it on to Maarten, but I can also give you a non-committal, balanced capital allocation going forward. And as I said, we're not allergic to share buybacks, especially at the current share price. And we don't have, i f we were to generate proceeds, we're not gonna have a hole burning in our pocket because of it. It's about making sure whatever we do creates value for Akzo and its shareholders. Thanks, Aaron. Other questions?

Aron Ceccarelli
Equity Research Analyst, Berenberg

Thank you. No, it's fine. Thank you very much, guys.

Greg Poux-Guillaume
CEO, AkzoNobel

Thanks.

Operator

We now have Alex Stewart with Barclays. You may proceed, Alex.

Alex Stewart
Director of European Chemicals Equity Research, Barclays

Hello, good morning. It's a real sign of the times that we haven't had a single question about raw materials. So perhaps I can sneak one in.

Greg Poux-Guillaume
CEO, AkzoNobel

Yeah.

Alex Stewart
Director of European Chemicals Equity Research, Barclays

You historically said that Q4 would be slightly inflationary. Crude is still at $75, petrochemical spreads are still pretty weak. Are you sticking with that guidance for the fourth quarter? And if I pushed you to talk about 2025, excluding whatever the tariffs affecting specific product chains, what's your medium-term outlook now for raws, given the conditions upstream? Thanks so much.

Maarten de Vries
CFO, AkzoNobel

Yeah, Alex, let me take that question. So, first of all, in Q3, raw material was still slightly down, as we have indicated before, so no change there. Q4, very consistent with our initial and original messages, slightly up. That's more driven by resins. You're making a link to the oil price, but there is not a direct link, more mid longer term link, but not a direct link. And if you're then going forward, we have always a kind of in six months visibility and e.g. what is happening with tariffs, there are no changes we're seeing versus the trends we see in Q4 going into Q1. I hope that give some color.

Alex Stewart
Director of European Chemicals Equity Research, Barclays

Okay, thank you. Thanks, Maarten. So I read about the first half of 2025, likely to be slightly inflationary. That's the conclusion I got. And then, maybe a follow-up. You said around EUR 1.5 billion for the year. Could you give us a kind of best case, worst case for the fourth quarter, and what the likely range of expectations are as you sit at the Exco level, to give some idea of what the main moving parts are for the final quarter, would be really helpful.

Maarten de Vries
CFO, AkzoNobel

No, Alex, what we've done, we've just refined our guidance. So we said we would be in the bottom of the range when we came out of Q2. I mean, given the fact that we have still two plus months to go, we have refined it and said that we will really be around the 1,500 to be much more precise, instead of saying that we will be certainly above the 1,500 in the bottom of the range. So that is the refinement we have done, and I would not read more into it.

Alex Stewart
Director of European Chemicals Equity Research, Barclays

Great. Thank you.

Greg Poux-Guillaume
CEO, AkzoNobel

Thanks, Alex. Other questions?

Operator

Thank you, Alex. We have another question from Georgina Fraser with Goldman Sachs. You may proceed.

Georgina Fraser
Equity Research Analyst, Goldman Sachs

Thank you very much. Good morning, Greg. Good morning, Maarten. Hope you're both doing well. I've got two questions left. One of them is a follow-up to Laurent's question on how to think about costs, for next year. Greg, you mentioned something earlier, in an answer about an inflation environment of 3%-4%. Is that what we should have in mind for 2025? And then my second question is related to the South Asia Deco review. What do you think this means for Akzo's group strategy? I mean, maybe Akzo didn't see it this way, but I've always thought of Akzo as being the developed market paint company that has emerging market growth exposure. So in the context of your strategic review, you know, where should investors see long-term growth coming from in your portfolio? Thank you.

Greg Poux-Guillaume
CEO, AkzoNobel

Thanks, Georgina. In terms of health, yeah, Maarten's doing really well, and, as a non-Dutch, I need to upgrade my company bicycle because this weather is getting to me, hence my voice. But it's... I'll survive. Yeah, the 3%-4% in terms of our planning assumptions, it's in that ballpark. We're not claiming to be the leading voice in the market in terms of macroeconomics, but at least in how we plan for the business, that's kind of what we're looking at. And then the South Asia thing, and your question on what is Akzo going forward? The way I'd answer the question is, Akzo going forward will be more geared towards coatings than Deco.

So right now, we're like 60/40, 60% coatings, 40% Deco, and we're likely to be higher than 60/40, higher than 60% in the future because we see ways to deploy capital in the coating businesses in ways that create differentiating scale. Because these are global businesses and these are still fragmented businesses, and therefore, you can add, you can bolt on additional positions that are virtuous in terms of scale, because essentially, it's the same product worldwide, to which you add additional markets or additional product ranges. On the Deco side, Deco is a regional market at best. More often, it's a local market, and Akzo is the market leader in Europe, but also a Deco player with emerging market exposure.

But not all emerging market exposure should be rated the same way. Emerging market exposure, where you're a market leader, you know, one or two, with enough scale in the market to differentiate versus some of the other players, that, that's good emerging market exposure. In markets where we're far from a leadership position, we have to figure out over time how we maximize value for Akzo, its people, and its shareholders. And sometimes that means partnering up. So we're not, you know, we're not making a bold statement out of, you know, we're exiting Deco emerging markets. We're not. We bought, for example, Orbis in Latin America, and we're very happy about this acquisition, and Latin America is performing really well for us. But when I look at Asia, I see a correlation between...

I mean, it's not only when you look at Asia, it's when you look at Deco overall. There's a correlation between profitability and relative market share. And what I mean, you know, relative market share is what your market share versus the largest player in the market. If you try to do that correlation, you'll see that this is not a bad correlation. So but it's. I'm only highlighting something that we all know, which is that in a local market, you know, paint is like cement. It's stuff that Deco. It's stuff that doesn't travel very far because the cost to weight ratio is not favorable to transporting very far.

So in all these markets where your radius is limited to what you can economically manage in terms of transport costs, it becomes about scale and distribution and impact of the brand, and that is directly linked to your relative market share. So that's what we're working on. And therefore, we're trying to make sure that we don't overestimate our ability to maximize the value of our businesses when we could do that more effectively, either in partnership with somebody else or by essentially passing on the business to somebody who's got you know, stronger local distribution. That's the essence of the review.

So it's a long answer to a short question, but hopefully it gives you a little bit of flavor as to how we think about this, Georgina.

Georgina Fraser
Equity Research Analyst, Goldman Sachs

Thanks very much, Greg. It does. Thank you.

Greg Poux-Guillaume
CEO, AkzoNobel

Thank you.

Operator

Thank you. We have our final question from Peter Clark with the Bernstein Société Générale Group. You may proceed.

Peter Clark
Managing Director and Senior Analyst, Bernstein Société Générale Group

Yes, good morning, everyone. I've got two questions and a clarification, please. The first question, just on the push into the new build again on the marine, just wondering how much of a margin drag that is at the moment for the performance coating segment, if it's meaningful? And then secondly, in terms of the guidance for the full year, the EUR 1.5 billion, which now infers the fourth quarter up, I think 10% or so on EBITDA to get there. I know you've got the softer hyperinflation comp or expected. Obviously, a lot of the cost cutting or more of the cost cutting coming through. But again, volume is important in the seasonally weak quarter, and volume's been disappointing both in Q2 and Q3. I know you're guiding flat, but you've got pretty tough comp.

Both segments have, I think, plus 3% in Q4 2023 in terms of volume growth. So just the confidence around that. And then just the clarification, Greg. Am I right in hearing you didn't say never say never at auto OEM with the color discussion around BASF?

Greg Poux-Guillaume
CEO, AkzoNobel

Let's see. You asked quite a few questions. We'll try to answer them all. The auto OEM thing, 'cause you ended with that, and my short-term memory is short, so I'll tackle it now. Auto OEM is a case of, I think, go big or go home. You don't want to be a small auto OEM player, but if you're a sizable auto OEM player like BASF is, you can actually make good money out of it, which they do. So it's... We're not allergic to that market. We're skeptical that you can be a winning player if you don't have the scale in that space. But, I mean, I'm commenting on other people's businesses.

So as you know, our auto OEM business is a few EUR 100 million , not more. Your question on marine, the new build business is dilutive to gross margin profitability, but it adds to the EBITDA at the bottom line. Because essentially, it is you know, the gross margin is lower than the dry docking, because dry docking is essentially aftermarket, and aftermarket always has higher profitability. But as long as you pick your battles, and you know, we notice that every time we talk about marine, Kenny forces me to say, "In the high-value ship marine new build market," which is a mouthful.

This is our way of saying we're not, you know, we're not going after, you know, like, basic container ships and bulk carriers. We're going after stuff where these are technical ships where whoever's commissioning the construction of that ship plans to use it for quite a while and is spending a lot of money on it because, you know, things like LNG, LPG carriers. And the people that do that, they want high-end solutions, they want sustainable solutions. They are more likely to go for bio-based anti-fouling. And they want to minimize the drag because this thing's gonna be in the water for a long time, and you need to also maximize your bang for the buck in terms of energy consumption.

So, that's a sweet spot for us, and then as we do that, then we still manage to do business at reasonable profitability levels. Therefore, we get the additional volume, and we minimize the gross margin dilution, while significantly contributing to the bottom line. So it's hopefully you understand the mechanics of it. We could grow faster in marine if we wanted to cast our net wider, but we're not trying to. I think the ratio in China is for every tender that we bid on, we decline to bid on probably another two. So it's not. We're not trying to maximize volume.

We're trying to maximize our hit rates in the sweet spot of the market, which is technical ships. Maarten, the question on how Q4 functions from a waterfall perspective.

Maarten de Vries
CFO, AkzoNobel

From a Q4 perspective, first of all, you mentioned already that, last year we had a EUR 23 million hyperinflation hit in our Q4 numbers. That we do expect that will not happen this year. So you could more calculate with the current trend of hyperinflation, which was EUR 6 million in the third quarter, and by the way, should start to come down a little bit. So that is one. Secondly, the volume trend, which we indicated and how we see it at the end of Q3, that is how we see it going forward. And we commented on it, and it will be more or less flat.

And then pricing perspective, we also commented specifically on industrial coatings that the indexing is kind of becoming lesser of an impact. So pricing will be flat to slightly positive.

Raw material, we commented already on it, which will be a slight impact on raw material. And then sequentially, we see further the OpEx sequentially will further come down, and that will be for Q4, flat to maybe slightly positive. So if you take all these elements into account, you get to our guidance of around EUR 1.5 billion for the year. I hope that gives color on the key elements for Q4.

Peter Clark
Managing Director and Senior Analyst, Bernstein Société Générale Group

Got it. Thank you. Thank you, both.

Operator

Thank you. We have our final question from Jaideep Pandya with Onfield Investment Research. Please go ahead.

Jaideep Pandya
Partner, On Field Investment Research

Thanks. I actually just have one question regarding the Deco business. Have you guys looked into the scenario of actually combining the whole Dulux business? And wouldn't it be sort of more interesting from a strategic point of view for somebody who wants to enter into Deco? Or is this, again, not an option because, you know, maybe exiting markets you want to exit on a case-by-case basis makes much more sense. And I think follow-up to a couple of the questions that has been asked, I mean, Greg, do you envisage a scenario if you go ahead and, you know, acquire BASF Coatings for Akzo to be a more of a pure play coatings company, and exit paints in, let's say in the long run? Thanks a lot.

Greg Poux-Guillaume
CEO, AkzoNobel

Yeah, thanks for your question. Well, the last question you asked, it will increase our proportion of coatings versus Deco. Because once again, as I explained earlier, we see ways to deploy capital in a way that creates value in the coating side because these are global businesses and still fairly fragmented. We don't, you know, we're not talking about exiting Deco. We're talking about making sure that our Deco positions are leading positions. Your question on Dulux overall, really two reasons why that is not something that we think would make sense. You know, essentially the idea of packaging all of Dulux and selling that to somebody. I mean, three reasons. One is actually, we like our Deco positions.

We just want them to be number one or number two positions. The second reason is that it already... You know, it's a regional or local markets, so the notion that you gain a whole lot by putting all of that together is slightly overblown. You gain through scale, for the scale, like scale of procurement, but, you know, there isn't anybody that buys Dulux in India because they've heard that Dulux is doing really well in Vietnam, you know? And then the final reason is, if you look at Dulux overall, it hasn't escaped you guys that Dulux in Australia is actually owned and run by Nippon.

So you already have large markets where Dulux is actually owned and managed by somebody else, just like, by the way, Huarun in China, which is a brand that Sherwin-Williams uses for its wood coatings business, is also the AkzoNobel Deco business. So, there's ample precedence in paints and coatings of brands that are being shared between multiple companies. The only limitation of that is that it works as long as the markets are independent of each other, and in Deco, they are. Hopefully, that answers your question?

Jaideep Pandya
Partner, On Field Investment Research

Yes. If I may just squeeze one follow-up on wood. Interesting you mentioned wood adhesives is doing well or has improved, but wood finish is not. Can you tell us what's going on in the wood market, and when have you seen the wood adhesives market improve?

Greg Poux-Guillaume
CEO, AkzoNobel

The wood adhesives market, it's a combination of wood adhesives and board resins. So, it's more construction-oriented than the wood finishes, which has a lot of furniture exposure, you know, things like kitchen cabinets. So I guess that tells you that there's wooden construction activity. You know, what are the countries that do construction with wood? I mean, the U.S. is picking up slightly. There's other, you know, Latin America. But the wood finishes, which is, you know, are you remodeling your kitchen or, you know, are you buying furniture? That's still slow. So, two different speeds, but they serve...

In the case of wood finishes, it's a lot of furniture. In the case of wood adhesives, it's a lot of construction. All right?

Jaideep Pandya
Partner, On Field Investment Research

Thank you.

Kenny Chae
Head of Investor Relations, AkzoNobel

Operator, I think we're ready to close.

Operator

Thank you.

Kenny Chae
Head of Investor Relations, AkzoNobel

Greg?

Greg Poux-Guillaume
CEO, AkzoNobel

Well, you're handing back to-

Operator

I can confirm that that's complete.

Greg Poux-Guillaume
CEO, AkzoNobel

So I'll hand back to myself. I want to thank everybody for spending time with us on this call. You know, we had something that we can qualify as a predictable and solid Q3. I'd like it to be more dynamic, but our markets currently don't lend themselves to that additional dynamism. We're still managing to extract volume growth out of markets that are tepid.

If you isolate Deco China, you see that the volume growth is actually more like in the 3%-4% range. And we're being disciplined on pricing, and we are taking a hammer to our cost base. And these things are progressively materializing, but they will continue over the next quarters.

Essentially, we feel that we have the pieces in place to support our midterm ambitions, and that we are making Akzo a strong business, a stronger business going forward. So, thanks for your time, thanks for your interest, and we'll talk to you soon.

Kenny Chae
Head of Investor Relations, AkzoNobel

Operator, please close the call. Thank you.

Powered by